<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04930913</url>
  </required_header>
  <id_info>
    <org_study_id>2020-1-7027</org_study_id>
    <nct_id>NCT04930913</nct_id>
  </id_info>
  <brief_title>Three-dimensional Ultrasound Applying in Assessment of Intrauterine Adhesions</brief_title>
  <official_title>The Value of Three-dimensional Ultrasound Applying in Pre and Postoperative Assessment and Prognosis of Intrauterine Adhesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fu Xing Hospital, Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fu Xing Hospital, Capital Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective, multicenter, large-scale study，the investigators wish to examine the&#xD;
      accuracy of several three-dimensional ultrasound anatomical and vascular parameters in&#xD;
      diagnosing IUA when compared to the gold standard of hysteroscopy，and to assess the value of&#xD;
      3D US applying in prognosis of intrauterine adhesions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Study Design This is a prospective, multicenter, large-scale diagnostic testing. We use&#xD;
           hysteroscopy finding as standard reference.&#xD;
&#xD;
        2. Study population 600 patients from three tertiary hospitals suspected of having IUA will&#xD;
           be prospectively recruited. Thorough assessment including previous reproductive and&#xD;
           surgical history as well as menstrual pattern will be performed.&#xD;
&#xD;
        3. Study Procedure 3.1 Diagnosis&#xD;
&#xD;
      IUA will be diagnosed in coronal plane, based on a suggestion reported by a Taiwanese study.&#xD;
      The morphological characteristics of the endometrium suggesting IUA include as follow:&#xD;
&#xD;
        -  marginal irregularity (in coronal plane)&#xD;
&#xD;
        -  defects (interrupted endometrial line)&#xD;
&#xD;
        -  obliteration (undetectable endometrium suggesting extensive adhesion)&#xD;
&#xD;
        -  fibrosis or calcification (hyperechoic lesion without posterior shadowing, or with&#xD;
           posterior shadowing) 3.2 Ultrasound&#xD;
&#xD;
        -  Transvaginal Ultrasound will be performed in luteal phase.&#xD;
&#xD;
        -  Using E10 Voluson GE with 3D/4D TV probe.&#xD;
&#xD;
        -  Scan and rendering will be performed in a standardized technique (omniview mode).&#xD;
&#xD;
        -  Several parameters will be measured including endometrial volume, uterine volume,&#xD;
           vascularization (VI FI VFI).&#xD;
&#xD;
      3.3 Hysteroscopy&#xD;
&#xD;
        -  Hysteroscopic exam will be used as the gold standard for the diagnosis of intrauterine&#xD;
           adhesions.&#xD;
&#xD;
        -  hysteroscopy will confirm the presence, extent, and morphological characteristics of&#xD;
           adhesions and the quality of the endometrium.&#xD;
&#xD;
      3.4 Surgical technique&#xD;
&#xD;
        -  Hysteroscopic surgery will be performed in a standardized manner.&#xD;
&#xD;
        -  The severity and extent of intrauterine adhesions will be scored according to different&#xD;
           classification systems. (ESGE/AFS/China consensus)&#xD;
&#xD;
        -  a Foley-catheter filled with 3.0ml normal saline will be inserted into the uterus for&#xD;
           5-7 days after surgery.&#xD;
&#xD;
      3.5 Postoperative treatments&#xD;
&#xD;
        -  All subjects will be treated with Hormone therapy for at least 8 weeks&#xD;
&#xD;
        -  A second-look hysteroscopy will be carried out 4 weeks after surgery, a third-look&#xD;
           hysteroscopy will be carried out 12 weeks after surgery&#xD;
&#xD;
        -  A second-look 3D US will be carried out in luteal phase after two menstrual peroid&#xD;
           postoperatively.&#xD;
&#xD;
      3.6 Follow up&#xD;
&#xD;
        -  Follow-up styles: the doctor's outpatient review, telephone, WeChat and so on.&#xD;
&#xD;
        -  Follow-up time:3 months, 6months, 12 months after the operation.&#xD;
&#xD;
        -  Follow up the results of hysteroscopy and 3D US at 3 months after the operation and the&#xD;
           menstrual improvement at 6months after the operation and pregnancy outcomes at 12 months&#xD;
           after the operation&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Endometrial volume</measure>
    <time_frame>1 year</time_frame>
    <description>Endometrial volume will be measured in in luteal phase by 3D US</description>
  </primary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Intrauterine Adhesion</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Three-dimensional Ultrasound</intervention_name>
    <description>women suspected of having adhesions will perform 3D US</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        600 patients from three Tertiary hospitals suspected of having IUA will be prospectively&#xD;
        recruited&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  women aged 20-40&#xD;
&#xD;
          -  oligomenorrhea or amenorrhea&#xD;
&#xD;
          -  BMI 18-30&#xD;
&#xD;
          -  regular menstruation&#xD;
&#xD;
          -  written consent obtained&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hypothalamic amenorrhea, pituitary amenorrhea and ovarian amenorrhea&#xD;
&#xD;
          -  Patients with uterine fibroids, adenomyosis, uterine malformation and endometrial&#xD;
             polyps&#xD;
&#xD;
          -  Patients with uterine artery embolization&#xD;
&#xD;
          -  History of endometrial hyperplasia&#xD;
&#xD;
          -  Irregular menstruation&#xD;
&#xD;
          -  Patients with severe complications&#xD;
&#xD;
          -  Patients with hypoovarian function&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Li Tinchiu</last_name>
    <role>Study Chair</role>
    <affiliation>Fuxing Hospital,Capital Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Huang xiaowu</last_name>
    <phone>+8613810828816</phone>
    <email>hxiaowu_fxyy@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fu Xing Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <zip>100038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>luo wen</last_name>
      <phone>+86 010-88062291</phone>
      <email>fxyykjk@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Kim MJ, Lee Y, Lee C, Chun S, Kim A, Kim HY, Lee JY. Accuracy of three dimensional ultrasound and treatment outcomes of intrauterine adhesion in infertile women. Taiwan J Obstet Gynecol. 2015 Dec;54(6):737-41. doi: 10.1016/j.tjog.2015.10.011.</citation>
    <PMID>26700995</PMID>
  </reference>
  <reference>
    <citation>Amin TN, Saridogan E, Jurkovic D. Ultrasound and intrauterine adhesions: a novel structured approach to diagnosis and management. Ultrasound Obstet Gynecol. 2015 Aug;46(2):131-9. doi: 10.1002/uog.14927. Epub 2015 Jul 20. Review.</citation>
    <PMID>26094824</PMID>
  </reference>
  <reference>
    <citation>Carrascosa P, Capuñay C, Vallejos J, Carpio J, Baronio M, Papier S. Two-dimensional and three-dimensional imaging of uterus and fallopian tubes in female infertility. Fertil Steril. 2016 Jun;105(6):1403-1420.e7. doi: 10.1016/j.fertnstert.2016.04.016. Epub 2016 Apr 29. Review.</citation>
    <PMID>27140290</PMID>
  </reference>
  <reference>
    <citation>AAGL Elevating Gynecologic Surgery. AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE). Gynecol Surg. 2017;14(1):6. doi: 10.1186/s10397-017-1007-3. Epub 2017 May 1.</citation>
    <PMID>28603474</PMID>
  </reference>
  <reference>
    <citation>Salazar CA, Isaacson K, Morris S. A comprehensive review of Asherman's syndrome: causes, symptoms and treatment options. Curr Opin Obstet Gynecol. 2017 Aug;29(4):249-256. doi: 10.1097/GCO.0000000000000378. Review.</citation>
    <PMID>28582327</PMID>
  </reference>
  <reference>
    <citation>Dreisler E, Kjer JJ. Asherman's syndrome: current perspectives on diagnosis and management. Int J Womens Health. 2019 Mar 20;11:191-198. doi: 10.2147/IJWH.S165474. eCollection 2019. Review.</citation>
    <PMID>30936754</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 11, 2021</study_first_submitted>
  <study_first_submitted_qc>June 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2021</study_first_posted>
  <last_update_submitted>June 16, 2021</last_update_submitted>
  <last_update_submitted_qc>June 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fu Xing Hospital, Capital Medical University</investigator_affiliation>
    <investigator_full_name>Xiaowu Huang</investigator_full_name>
    <investigator_title>Director of department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Adhesions</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

